Bone Biologics (BBLG) Change in Cash (2016 - 2017)
Historic Change in Cash for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$931700.0.
- Bone Biologics' Change in Cash fell 127301.42% to -$931700.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $69904.0, marking a year-over-year increase of 11412.96%. This contributed to the annual value of $6.7 million for FY2021, which is 2774698.7% up from last year.
- Latest data reveals that Bone Biologics reported Change in Cash of -$931700.0 as of Q4 2017, which was down 127301.42% from $838965.0 recorded in Q3 2017.
- Over the past 5 years, Bone Biologics' Change in Cash peaked at $3.1 million during Q1 2016, and registered a low of -$2.0 million during Q2 2016.